SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-187934
Filing Date
2020-07-06
Accepted
2020-07-06 17:23:28
Documents
5
Effectiveness Date
2020-07-06

Document Format Files

Seq Description Document Type Size
1 S-8 d935320ds8.htm S-8 68072
2 EX-5.1 d935320dex51.htm EX-5.1 9838
3 EX-23.1 d935320dex231.htm EX-23.1 1975
4 EX-99.3 d935320dex993.htm EX-99.3 44890
5 GRAPHIC g935320g0702174148467.jpg GRAPHIC 2176
  Complete submission text file 0001193125-20-187934.txt   129003
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239712 | Film No.: 201014351
SIC: 2834 Pharmaceutical Preparations